Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6221028 | The Journal of Pediatrics | 2015 | 6 Pages |
Abstract
K2 is a synthetic cannabinoid that has potential cardiovascular side effects, including myocardial ischemia, myocardial infarction, and arrhythmias. Cardiac testing of pediatric patients is often not performed owing to a lack of symptomatology. We report a series of pediatric patients with concern for myocardial ischemia temporally associated with K2 exposure.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Perinatology, Pediatrics and Child Health
Authors
Bradley C. MD, Justin MD, Charles I. MD,